The Epistar concept further streamlines the operation of the commonly used “auto-injecting medications” for controlling anaphylactic reactions. Anaphylaxis is a potentially fatal allergic reaction caused by various unfamiliar substances encountering with the human body. The EPISTAR could benefit fifty-million allergy sufferers in North America that can be potentially at risk of anaphylaxis. The Epistar is constructed with lightweight yet durable medical grade plastics and is carefully designed for providing excellent ergonomics during operation